NGM Bio Holdings, Inc.Amended

Biotechnology · SOUTH SAN FRANCISCO, CA

BiotechnologySEC Form D

NGM Bio Holdings, Inc. filed a Form D with the U.S. Securities and Exchange Commission on March 27, 2026, reporting $142,039,949 raised.

Incorporated in Delaware and based in SOUTH SAN FRANCISCO, CA, it operates in the Biotechnology sector.

Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that NGM Bio Holdings, Inc. has raised capital from private investors.

Browse more recently funded companies in Biotechnology.

Executives & Directors

  • Roger M. PerlmutterDirector
  • Peter SvennilsonDirector
  • Diana Peng BockusExecutive Officer · Director
  • Tim KutzkeyDirector

Recently funded in Biotechnology

Other companies that recently filed a Form D

$3.2MRaised

Goldenrod Therapeutics, Inc.

BiotechnologyHOUSTON, TX
May 26, 2026View SEC Form D
$10.0MRaised

Human Biotech, Inc.

BiotechnologyCAMBRIDGE, MA
May 22, 2026View SEC Form D
$1.0MRaised

Optimeos Life Sciences, Inc.

BiotechnologyPRINCETON, NJ
May 22, 2026View SEC Form D
$2.5MRaised

BioStem Technologies, Inc.

BiotechnologyPOMPANO BEACH, FL
May 21, 2026View SEC Form D
$1.6MRaised

Biolexis Therapeutics Inc.

BiotechnologyLEHI, UT
May 20, 2026View SEC Form D
NGM Bio Holdings, Inc. raised $142.0M — SEC Form D